NASDAQ
American Oriental Bioengineering, Inc. (AOBI) has a revenue compound annual growth rate of -2.00% over 5 years and 30.41% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.